Adenosine signalling in T-cell activation favours development of IL-17 positive cells with suppressive properties.

Leikeim, Lisa; Li, Hui; An, Liying; Sticht, Carsten; Krämer, Bernhard K; Yard, Benito; Leipe, Jan; Kälsch, Anna-Isabelle

Leikeim, Lisa; Li, Hui; An, Liying; Sticht, Carsten; Krämer, Bernhard K; Yard, Benito; Leipe, Jan; Kälsch, Anna-Isabelle.

Afiliación

Leikeim L; Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Li H; Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
An L; Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Sticht C; NGS Core Facility, Medical Faculty Mannheim, University of Heidelberg, Germany.
Krämer BK; Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.
Yard B; Center for Innate Immunoscience Mannheim, University of Heidelberg, Mannheim, Germany.
Leipe J; European Center for Angioscience, Mannheim, Germany.
Kälsch AI; Fifth Department of Medicine, University Hospital Mannheim, Heidelberg University, Mannheim, Germany.

Immunology ; 169(1): 42-56, 2023 05.

Article en En | MEDLINE | ID: mdl-36373432

Asunto(s)

Adenosina; Interleucina-17; Humanos; Animales; Ratones; Adenosina/metabolismo; Adenosina/farmacología; Adenosina-5'-(N-etilcarboxamida)/metabolismo; Adenosina-5'-(N-etilcarboxamida)/farmacología; Diferenciación Celular; Células Th17; Citocinas/metabolismo; Linfocitos T Reguladores

Palabras clave

Th17; cell differentiation; human; inflammation; regulation/suppression

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Adenosina / Interleucina-17 Límite: Animals / Humans Idioma: En Revista: Immunology Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google